Cardiovascular Toxicities from Systemic Breast Cancer Therapy

Cardiovascular toxicity is unfortunately a potential short- or long-term sequela of breast cancer therapy. Both conventional chemotherapeutic agents such as anthracyclines and newer targeted agents such as trastuzumab can cause varying degrees of cardiac dysfunction. Type I cardiac toxicity is dose-...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Shuang, Wong, Serena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255485/
https://www.ncbi.nlm.nih.gov/pubmed/25538891
http://dx.doi.org/10.3389/fonc.2014.00346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255485/
https://www.ncbi.nlm.nih.gov/pubmed/25538891
http://dx.doi.org/10.3389/fonc.2014.00346

Ejemplares similares